ITB-MED logo — company profile

ITB-MED

Founded 2016 United States New York, United States 56 employees Series Unknown Biotechnology, Pharmaceutical

General Information

Company Name ITB-MED
Founded Year 2016
Location United States New York, United States +2
Employees 56
Industries Biotechnology, Pharmaceutical
Funding Stage Series Unknown
Social

Get notified when ITB-MED moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About ITB-MED

ITB-MED is developing the proprietary antagonistic CD2-directed monoclonal antibody, TCD601 (siplizumab), for several indications. ITB-MED is wholly committed to advancing and exploring the potential of TCD601, with a particular focus on its applications in transplantation and autoimmunity. The efforts extend to comprehensive worldwide clinical trials. ITB-MED is actively investigating further preclinical therapies to expand the reach of its novel immune-modulating approaches.

No funding data available for ITB-MED yet.

Get notified when ITB-MED raises funding

ITB-MED Alternatives & Competitors

ITB-MED vs
PT LAPI ITB
PT LAPI ITB Indonesia

Delivering Solutions and Innovations that Matter

573 employees
ITB-MED vs

Digital Transformation & Innovation Company

Seed
30 employees
ITB-MED vs
ITB, Inc.
ITB, Inc. United States

INNOVATIVE ENGINEERING, MANAGEMENT, SCIENCE AND TECHNOLOGY SOLUTIONS Throughout the DoD, bran...

18 employees
Government and Military, Information Technology

FAQ About ITB-MED

ITB-MED is developing the proprietary antagonistic CD2-directed monoclonal antibody, TCD601 (siplizumab), for several indications. ITB-MED is wholly committed to advancing and exploring the potential of TCD601, with a particular focus on its applications in transplantation and autoimmunity. The effo...
ITB-MED was founded in 2016.
ITB-MED is headquartered in New York, United States.
ITB-MED operates in the following industries: Biotechnology, Pharmaceutical.
ITB-MED has approximately 56 employees.
Top alternatives and competitors to ITB-MED include PT LAPI ITB, PT Svara Inovasi Indonesia (SVARA), ITB, Inc., ITB Worldwide, MarkPlus Institute. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ITB-MED and PT LAPI ITB are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors ITB-MED and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy